• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿每日一次奈替米星(6毫克/千克)的药代动力学。

Pharmacokinetics of once-a-day netilmicin (6 mg/kg) in neonates.

作者信息

Ettlinger J J, Bedford K A, Lovering A M, Reeves D S, Speidel B D, MacGowan A P

机构信息

Department of Neonatal Medicine, Southmead Health Services NHS Trust, Southmead Hospital, Westbury-on-Trym, Bristol, UK.

出版信息

J Antimicrob Chemother. 1996 Sep;38(3):499-505. doi: 10.1093/jac/38.3.499.

DOI:10.1093/jac/38.3.499
PMID:8889724
Abstract

The pharmacokinetics of once a day netilmicin (6 mg/kg) was studied in 21 neonates. The babies were divided into three groups according to gestational age: group I aged > 36 weeks; group II between 34-36 weeks and group III < 34 weeks. Serum concentrations were variable between patients and the concentration 24 h after the first dose ranged from 0.8 to 3.8 mg/L with only two babies having concentrations of < 1 mg/L while seven had concentrations of > 2 mg/L. There were also large patient-to-patient variations in serum half-life, volume of distribution, area under the curve and relative plasma clearance such that these parameters could not be correlated to gestational age or weight. Absolute plasma clearance was correlated with both gestational age and weight. There was evidence of accumulation between the first and second dose for all three patient groups and for patients of gestational age < 34 weeks (group III) these observations were statistically significant. A netilmicin dosage of 4.5 mg/kg once a day may be more suitable for all neonates supported by assay of serum concentrations.

摘要

对21例新生儿进行了一日一次奈替米星(6mg/kg)的药代动力学研究。根据胎龄将婴儿分为三组:第一组胎龄>36周;第二组胎龄在34 - 36周之间;第三组胎龄<34周。患者之间血清浓度存在差异,首剂给药后24小时的浓度范围为0.8至3.8mg/L,只有两名婴儿的浓度<1mg/L,而七名婴儿的浓度>2mg/L。血清半衰期、分布容积、曲线下面积和相对血浆清除率在患者之间也存在很大差异,因此这些参数与胎龄或体重无关。绝对血浆清除率与胎龄和体重均相关。所有三个患者组在首剂和第二剂之间均有蓄积迹象,对于胎龄<34周的患者(第三组),这些观察结果具有统计学意义。根据血清浓度测定结果,一日一次4.5mg/kg的奈替米星剂量可能更适合所有新生儿。

相似文献

1
Pharmacokinetics of once-a-day netilmicin (6 mg/kg) in neonates.新生儿每日一次奈替米星(6毫克/千克)的药代动力学。
J Antimicrob Chemother. 1996 Sep;38(3):499-505. doi: 10.1093/jac/38.3.499.
2
Pharmacokinetics of once-a-day netilmicin (4.5 mg/kg) in neonates.新生儿每日一次奈替米星(4.5毫克/千克)的药代动力学。
J Chemother. 2001 Jun;13(3):270-6. doi: 10.1179/joc.2001.13.3.270.
3
[Pharmacokinetics of netilmicin in neonates].奈替米星在新生儿中的药代动力学
Med Wieku Rozwoj. 2003 Oct-Dec;7(4 Pt 2):547-55.
4
Population pharmacokinetic analysis of netilmicin in neonates and infants with use of a nonparametric method.使用非参数方法对新生儿和婴儿奈替米星进行群体药代动力学分析。
Clin Pharmacol Ther. 2000 Jun;67(6):600-9. doi: 10.1067/mcp.2000.106695.
5
Pharmacokinetics of a netilmicin loading dose on the first postnatal day in preterm neonates with very low gestational age.极低胎龄早产儿出生后第一天奈替米星负荷剂量的药代动力学
Eur J Clin Pharmacol. 2006 Sep;62(9):773-7. doi: 10.1007/s00228-006-0153-8. Epub 2006 Jul 25.
6
Netilmicin in the neonate: population pharmacokinetic analysis and dosing recommendations.新生儿使用奈替米星:群体药代动力学分析及给药建议。
Clin Pharmacol Ther. 1991 Jul;50(1):55-65. doi: 10.1038/clpt.1991.103.
7
[Optimalisation of netilmicin dosage based on therapeutic drug monitoring during the first days of life in very preterm neonates (gestational age 23-32 weeks)].[基于治疗药物监测的极低出生体重儿(胎龄23 - 32周)出生后最初几天奈替米星剂量的优化]
Med Wieku Rozwoj. 2009 Oct-Dec;13(4):252-9.
8
Pharmacokinetic assessment of netilmicin in newborns and older children.奈替米星在新生儿和大龄儿童中的药代动力学评估。
Infection. 1982;10(3):153-8. doi: 10.1007/BF01640766.
9
[Pharmacokinetics of netilmicin in the first use in newborn infants with gestational ages greater than 34 weeks].[奈替米星在孕龄大于34周的新生儿首次使用时的药代动力学]
Arch Pediatr. 1994 May;1(5):481-8.
10
Validation of a simplified netilmicin dosage regimen in infants.简化奈替米星给药方案在婴儿中的验证
Scand J Infect Dis. 2004;36(6-7):474-9. doi: 10.1080/00365540410020613.

引用本文的文献

1
Clinical Pharmacokinetics of Penicillins, Cephalosporins and Aminoglycosides in the Neonate: A Review.新生儿期青霉素类、头孢菌素类和氨基糖苷类药物的临床药代动力学:综述
Pharmaceuticals (Basel). 2010 Aug 12;3(8):2568-2591. doi: 10.3390/ph3082568.
2
Clinical Pharmacology Studies in Critically Ill Children.危重症儿童的临床药理学研究
Pharm Res. 2017 Jan;34(1):7-24. doi: 10.1007/s11095-016-2033-y. Epub 2016 Sep 1.
3
Netilmicin in the neonate: pharmacokinetic analysis and influence of parenteral nutrition.新生儿使用奈替米星:药代动力学分析及肠外营养的影响
Pharm World Sci. 2009 Jun;31(3):365-8. doi: 10.1007/s11096-009-9278-z. Epub 2009 Jan 25.
4
Clinical pharmacokinetics of aminoglycosides in the neonate: a review.新生儿氨基糖苷类药物的临床药代动力学:综述
Eur J Clin Pharmacol. 2009 Apr;65(4):419-27. doi: 10.1007/s00228-008-0599-y. Epub 2008 Dec 23.
5
Individualising netilmicin dosing in neonates.新生儿奈替米星给药个体化
Eur J Clin Pharmacol. 2008 Dec;64(12):1201-8. doi: 10.1007/s00228-008-0536-0. Epub 2008 Aug 7.
6
Pharmacokinetics of a netilmicin loading dose on the first postnatal day in preterm neonates with very low gestational age.极低胎龄早产儿出生后第一天奈替米星负荷剂量的药代动力学
Eur J Clin Pharmacol. 2006 Sep;62(9):773-7. doi: 10.1007/s00228-006-0153-8. Epub 2006 Jul 25.
7
Population pharmacokinetics of netilmicin in short-term prophylactic treatment.奈替米星在短期预防性治疗中的群体药代动力学。
Br J Clin Pharmacol. 2003 Jun;55(6):552-9. doi: 10.1046/j.1365-2125.2003.01783.x.
8
Nonparametric population pharmacokinetic analysis of amikacin in neonates, infants, and children.新生儿、婴儿和儿童中阿米卡星的非参数群体药代动力学分析。
Antimicrob Agents Chemother. 2002 May;46(5):1381-7. doi: 10.1128/AAC.46.5.1381-1387.2002.